Pseudoaneurysm

Outlook on the Vascular Patches Global Market to 2025 - Increasing Adoption of Biological Patches is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Friday, January 29, 2021
Medical devices, Health, Medical specialties, Anatomy, Angiology, Gross pathology, Vascular surgery, Vascular diseases, IgG4-related disease, Aneurysm, Aortic aneurysm, Pseudoaneurysm, Aorta, Open aortic surgery

A small, localized saccular pseudoaneurysm of the aorta is often treated with quick patch repair rather than tube graft replacement.

Key Points: 
  • A small, localized saccular pseudoaneurysm of the aorta is often treated with quick patch repair rather than tube graft replacement.
  • This factor is also expected to increase the incidence of aortic aneurysm, which will increase the demand for vascular patches, helping in the market growth.
  • North America holds the largest share in the vascular patches market, with the United States being the largest contributor to its revenue.
  • Additionally, the increasing prevalence of vascular diseases is the major factor expected to drive the overall growth of the market, during the forecast period.

Generex Biotechnology Subsidiary Olaregen Therapeutix Announces Publication on the Use of Excellagen® for Vascular Repair

Retrieved on: 
Thursday, August 13, 2020
Gross pathology, Pseudoaneurysm, Surgery

Rapid healing of the vascular surgical repair site is needed to prevent recurrence or progression of the pseudoaneurysm.

Key Points: 
  • Rapid healing of the vascular surgical repair site is needed to prevent recurrence or progression of the pseudoaneurysm.
  • Using Excellagen from Generexs subsidiary, Olaregen Therapeutix, the surgeons at Yale and the Connecticut VA demonstrated a simple, safe and effective approach to pseudoaneurysm repair.
  • As this peer-reviewed publication demonstrates, Excellagen can be used successfully in complex vascular surgeries like pseudoaneurysm repair to promote healing that lead to better patient outcomes.
  • Generex undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.